• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测定液体制剂口服剂型中盐酸雷尼替丁的经验证的稳定性指示液相色谱法。

A validated stability-indicating liquid-chromatographic method for ranitidine hydrochloride in liquid oral dosage form.

作者信息

Sharma Nitish, Rao Surendra Singh, Kumar Namala Durga Atchuta, Reddy Pingili Sunil, Reddy Annarapu Malleswara

机构信息

Analytical Research and Development, IPDO, Dr. Reddy's Laboratories Ltd. Bachupally, Hyderabad-500072, A.P, India.

出版信息

Sci Pharm. 2011 Apr-Jun;79(2):309-22. doi: 10.3797/scipharm.1101-06. Epub 2011 Feb 12.

DOI:10.3797/scipharm.1101-06
PMID:21773068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3134857/
Abstract

A selective, specific and stability-indicating gradient reverse phase high-performance liquid chromatographic (HPLC) method was developed for the determination of Ranitidine in presence of its impurities, forced degradation products and placebo substances such as saccharide and parabens. Ultraviolet detection was performed at 230 nm. Separate portions of the drug product and ingredients were exposed to stress conditions to induce oxidative, acidic, basic, hydrolytic, thermal and photolytic degradation. Ranitidine was found to degrade significantly at acidic, basic and oxidative stress conditions but was stable at heat and humidity. The developed method was validated as per International Conference on Harmonization (ICH) guidelines. The method was validated over this range for (i) system suitability (ii) specificity, (iii) precision, (iv) limit of detection and limit of quantification, (v) linearity, (vi) accuracy, (vii) robustness. The method was found to be precise, accurate, linear and robust. The proposed method was successfully employed for estimation of Ranitidine impurities in pharmaceutical preparations.

摘要

建立了一种选择性、特异性且具有稳定性指示功能的梯度反相高效液相色谱(HPLC)法,用于在存在杂质、强制降解产物以及安慰剂物质(如糖类和对羟基苯甲酸酯类)的情况下测定雷尼替丁。在230nm处进行紫外检测。将药品和成分的不同部分置于应激条件下,以诱导氧化、酸性、碱性、水解、热解和光解降解。结果发现雷尼替丁在酸性、碱性和氧化应激条件下会显著降解,但在加热和潮湿条件下稳定。所建立的方法按照国际协调会议(ICH)指南进行了验证。该方法在该范围内针对以下方面进行了验证:(i)系统适用性;(ii)特异性;(iii)精密度;(iv)检测限和定量限;(v)线性;(vi)准确度;(vii)稳健性。结果表明该方法精密、准确、线性良好且稳健。所提出的方法成功用于药物制剂中雷尼替丁杂质的测定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb52/3134857/314f8de26fdb/scipharm-2011-79-309f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb52/3134857/6149a57d6625/scipharm-2011-79-309f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb52/3134857/5b855cd53aba/scipharm-2011-79-309f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb52/3134857/314f8de26fdb/scipharm-2011-79-309f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb52/3134857/6149a57d6625/scipharm-2011-79-309f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb52/3134857/5b855cd53aba/scipharm-2011-79-309f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb52/3134857/314f8de26fdb/scipharm-2011-79-309f3a.jpg

相似文献

1
A validated stability-indicating liquid-chromatographic method for ranitidine hydrochloride in liquid oral dosage form.一种用于测定液体制剂口服剂型中盐酸雷尼替丁的经验证的稳定性指示液相色谱法。
Sci Pharm. 2011 Apr-Jun;79(2):309-22. doi: 10.3797/scipharm.1101-06. Epub 2011 Feb 12.
2
UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.超高效液相色谱法(UPLC)和液相色谱 - 质谱联用(LC - MS)对盐酸伊立替康降解行为的研究以及开发一种经验证的稳定性指示超高效液相色谱法,用于测定药物剂型中盐酸伊立替康及其杂质。
J Chromatogr Sci. 2012 Oct;50(9):810-9. doi: 10.1093/chromsci/bms075. Epub 2012 Jun 1.
3
Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.用于测定活性药物成分和药物制剂中缬沙坦及其降解产物的稳定性指示型 UPLC 方法。
J Pharm Biomed Anal. 2010 Nov 2;53(3):483-9. doi: 10.1016/j.jpba.2010.05.022.
4
A novel validated stability indicating high performance liquid chromatographic method for estimation of degradation behavior of ciprofloxacin and tinidazole in solid oral dosage.一种新型经验证的稳定性指示高效液相色谱法,用于评估环丙沙星和替硝唑在固体口服制剂中的降解行为。
J Pharm Bioallied Sci. 2013 Oct;5(4):298-308. doi: 10.4103/0975-7406.120082.
5
A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms.一种用于原料药及药物制剂中兰索拉唑及其杂质测定的新型、经过验证的稳定性指示超高效液相色谱法。
Sci Pharm. 2013 Jan-Mar;81(1):183-93. doi: 10.3797/scipharm.1210-09. Epub 2012 Dec 3.
6
Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.建立并验证了一种新型的 HPLC 稳定性指示法,用于定量测定依泽替米贝原料药及制剂中十一相关物质。
Talanta. 2015 Jul 1;139:67-74. doi: 10.1016/j.talanta.2015.02.039. Epub 2015 Feb 27.
7
A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms.用于药物制剂中地氯雷他定及其杂质的经验证的稳定性指示 UPLC 方法。
J Pharm Biomed Anal. 2010 Feb 5;51(3):736-42. doi: 10.1016/j.jpba.2009.09.016. Epub 2009 Sep 20.
8
Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form.用于原料药和药物剂型中萘普生及其杂质测定的新型经验证的稳定性指示超高效液相色谱法
Sci Pharm. 2012 Oct-Dec;80(4):965-76. doi: 10.3797/scipharm.1207-12. Epub 2012 Sep 9.
9
A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.一种用于眼用剂型中盐酸多佐胺和马来酸噻吗洛尔相关物质的新颖且快速验证的稳定性指示超高效液相色谱法。
J Chromatogr Sci. 2012 Oct;50(9):745-55. doi: 10.1093/chromsci/bms025. Epub 2012 May 4.
10
Development of a Stability-Indicating RP-HPLC Method for the Determination of Rupatadine and its Degradation Products in Solid Oral Dosage Form.开发一种用于测定固体口服制剂中卢帕他定及其降解产物的稳定性指示反相高效液相色谱法。
Sci Pharm. 2012 Oct-Dec;80(4):889-902. doi: 10.3797/scipharm.1208-10. Epub 2012 Oct 1.

本文引用的文献

1
A novel gradient HPLC method for simultaneous determination of ranitidine, methylparaben and propylparaben in oral liquid pharmaceutical formulation.一种用于同时测定口服液体制剂中雷尼替丁、对羟基苯甲酸甲酯和对羟基苯甲酸丙酯的新型梯度高效液相色谱法。
J Pharm Biomed Anal. 2005 Jul 15;38(4):763-7. doi: 10.1016/j.jpba.2005.02.022. Epub 2005 Mar 23.
2
Simultaneous determination of ranitidine and metronidazole in human plasma using high performance liquid chromatography with diode array detection.采用高效液相色谱-二极管阵列检测法同时测定人血浆中雷尼替丁和甲硝唑的含量。
J Pharm Biomed Anal. 2005 Apr 1;37(4):777-83. doi: 10.1016/j.jpba.2004.11.042. Epub 2004 Dec 28.
3
Development of an HPLC method for the determination of ranitidine and cimetidine in human plasma following SPE.
J Pharm Biomed Anal. 2003 Sep 19;33(2):165-73. doi: 10.1016/s0731-7085(03)00265-6.
4
Optimisation, validation and application of a capillary electrophoresis method for the determination of ranitidine hydrochloride and related substances.一种用于测定盐酸雷尼替丁及有关物质的毛细管电泳方法的优化、验证及应用
J Chromatogr A. 1998 Mar 6;798(1-2):297-306. doi: 10.1016/s0021-9673(97)01179-5.
5
High-performance liquid chromatographic methods for the determination of ranitidine and related substances in raw materials and tablets.
J Pharm Sci. 1988 Oct;77(10):889-92. doi: 10.1002/jps.2600771016.
6
Chromatographic methods for determining the identity, strength and purity of ranitidine hydrochloride both in the drug substance and its dosage forms--an exercise in method selection, development, definition and validation.
J Pharm Biomed Anal. 1989;7(1):1-22. doi: 10.1016/0731-7085(89)80062-7.